Clin2
NCT06811025Possibly a fitEnrolling by invitation

Contezolid for treating tuberculous meningitis

TuberculosisMeningitis

Treatments studied

Part of Brain & nervous system, Infections clinical trials.

This trial tests a new antibiotic called contezolid for people with tuberculous meningitis, an infection of the brain lining. The goal is to see if it works well and is safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
24 people
Ages
Any age
Study type
Interventional

Who can take part

  • Diagnosed with tuberculous meningitis within the past 3 months
  • Currently hospitalized
  • Willing to use effective birth control during the study and for 1 month after
  • No long-term steroid or immunosuppressant use in the last 90 days
  • Not pregnant, breastfeeding, or within 6 weeks after giving birth
  • No known allergy or previous bad reaction to contezolid or linezolid

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06811012Enrolling by invitation· Phase 1/Phase 2
Testing Contezolid for Bone and Joint Tuberculosis

This trial tests an antibiotic called contezolid for people with bone or joint tuberculosis. It aims to see if the drug can treat the infection effectively.

Beijing, Beijing Municipality
NCT05534750Recruiting· Phase 2
Early test of two antibiotics for new lung TB

This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.

Paris
NCT07372781Enrolling by invitation· Phase 2
Contezolid for mycobacterium abscessus lung infection

This study tests whether a new antibiotic, Contezolid, can quickly reduce the amount of Mycobacterium abscessus in your lungs. It may be a treatment option if you have had a positive sputum test in the past 6 months.

Beijing, Beijing Municipality
NCT06905522Recruiting· Phase 3
Tuberculosis treatment trial for new patients

This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.

Beijing
NCT07084402Recruiting· Phase 4
Effect of Contezolid on MAC lung disease

This trial tests whether the drug Contezolid can quickly kill the bacteria that cause MAC lung disease, a type of lung infection. It is for people who have not been treated for this infection in the last 3 months.

Beijing, Beijing Municipality
NCT05917340Not yet recruiting· Phase 3
Tested short TB meningitis treatment with stronger follow-up

This trial tests an intensified, shorter treatment plan for TB meningitis (TB in the lining around the brain) in adults, including people with HIV. It may help some patients get better with a structured plan while researchers compare treatment outcomes and safety.

Chennai, Tamil Nadu

Hear when a new Tuberculosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.